{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:28:44Z","timestamp":1790188124239,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["20220204037YY"],"award-info":[{"award-number":["20220204037YY"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115485","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T16:16:10Z","timestamp":1694794570000},"page":"115485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Albumin nanoparticles and their folate modified counterparts for delivery of a lupine derivative to hepatocellular carcinoma"],"prefix":"10.1016","volume":"167","author":[{"given":"Haohao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2023.115485_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.biopha.2023.115485_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115485_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000658-200102000-00013","article-title":"Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma","volume":"233","author":"Lau","year":"2001","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2023.115485_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2023.115485_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","article-title":"Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence","volume":"72","author":"Raoul","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2023.115485_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/14728222.2019.1685501","article-title":"RAS\/RAF\/MEK\/ERK, PI3K\/PTEN\/AKT\/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma","volume":"23","author":"Akula","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"issue":"15","key":"10.1016\/j.biopha.2023.115485_bib7","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.3390\/ijms21155232","article-title":"Molecular targets, pathways, and therapeutic implications for hepatocellular carcinoma","volume":"21","author":"Gong","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115485_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0794-6","article-title":"Emerging agents and regimens for hepatocellular carcinoma","volume":"12","author":"Zhu","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115485_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nrclinonc.2015.103","article-title":"Advances in targeted therapies for hepatocellular carcinoma in the genomic era","volume":"12","author":"Llovet","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115485_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fphar.2016.00428","article-title":"Angiogenesis inhibitors for the treatment of hepatocellular carcinoma","volume":"7","author":"Berretta","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115485_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.114428","article-title":"Targeted therapy for hepatocellular carcinoma: challenges and opportunities","volume":"460","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"issue":"34","key":"10.1016\/j.biopha.2023.115485_bib12","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.1016\/j.biomaterials.2014.07.062","article-title":"An albumin-based theranostic nano-agent for dual-modal imaging guided photothermal therapy to inhibit lymphatic metastasis of cancer post surgery","volume":"35","author":"Chen","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2023.115485_bib13","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2147\/IJN.S153107","article-title":"Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII","volume":"13","author":"Lu","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.biopha.2023.115485_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2023.115485_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40591-016-0048-8","article-title":"Albumin-based drug delivery: harnessing nature to cure disease","volume":"4","author":"Larsen","year":"2016","journal-title":"Mol. Cell. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2023.115485_bib16","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3109\/21691401.2015.1129617","article-title":"Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art","volume":"44","author":"Rahman","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115485_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","article-title":"Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance","volume":"15","author":"Gonen","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.biopha.2023.115485_bib18","article-title":"Preparation and evaluation of folate-decorated human serum albumin nanoparticles for the targeted delivery of sorafenib to enhance antihepatocarcinoma efficacy","volume":"54","author":"Gao","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115485_bib19","first-page":"154","article-title":"Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors, Artificial cells","volume":"47","author":"Lian","year":"2019","journal-title":"Nanomed., Biotechnol."},{"key":"10.1016\/j.biopha.2023.115485_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2019.08.016","article-title":"Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma","volume":"69","author":"Elnaggar","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"20","key":"10.1016\/j.biopha.2023.115485_bib21","doi-asserted-by":"crossref","first-page":"23311","DOI":"10.1021\/acsami.0c02785","article-title":"Phospholipid-decorated glycogen nanoparticles for stimuli-responsive drug release and synergetic chemophotothermal therapy of hepatocellular carcinoma","volume":"12","author":"Zhou","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2023.115485_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14786419.2020.1856840","article-title":"Cytotoxic and anti-tumor effects of 3, 4-seco-lupane triterpenoids from the leaves of Eleutherococcus sessiliflorus against hepatocellular carcinoma","author":"Wang","year":"2020","journal-title":"Nat. Prod. Res."},{"issue":"16","key":"10.1016\/j.biopha.2023.115485_bib23","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1080\/14786419.2019.1656622","article-title":"3, 4-seco-lupane triterpene derivatives with cytotoxic activities from the leaves of Eleutherococcus sessiliflorus","volume":"35","author":"Zhang","year":"2021","journal-title":"Nat. Prod. Res."},{"issue":"9","key":"10.1016\/j.biopha.2023.115485_bib24","first-page":"1334","article-title":"Noble 3, 4-Seco-triterpenoid glycosides from the fruits of Acanthopanax sessiliflorus and their anti-neuroinflammatory effects","volume":"10","author":"Choi","year":"2021","journal-title":"Antioxid. Redox Signal."},{"issue":"06","key":"10.1016\/j.biopha.2023.115485_bib25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0029-1185330","article-title":"Triterpenes from Acanthopanax sessiliflorus fruits and their antiplatelet aggregation activities","volume":"75","author":"Yang","year":"2009","journal-title":"Planta Med."},{"issue":"14","key":"10.1016\/j.biopha.2023.115485_bib26","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1021\/acs.jmedchem.2c00664","article-title":"Seco-lupane triterpene derivatives induce ferroptosis through GPX4\/ACSL4 axis and target cyclin D1 to block the cell cycle","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2023.115485_bib27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/bab.2399","article-title":"Fabrication of bovine serum albumin\u2010polyethylene glycol nanoparticle conjugated\u2010folic acid loaded\u2010naringenin as an efficient carrier biomacromolecule for suppression of cancer cells","volume":"70","author":"Firouzabadi","year":"2023","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.biopha.2023.115485_bib28","article-title":"Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: Synthesis, optimisation and in vitro biological evaluation","volume":"623","author":"Kunde","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115485_bib29","doi-asserted-by":"crossref","DOI":"10.1039\/C8BM00625C","article-title":"FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor","volume":"6","author":"Shi","year":"2018","journal-title":"Biomater. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2023.115485_bib30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3390\/cancers11101571","article-title":"Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel","volume":"11","author":"Meng","year":"2019","journal-title":"Cancers"},{"issue":"32","key":"10.1016\/j.biopha.2023.115485_bib31","doi-asserted-by":"crossref","first-page":"40643","DOI":"10.1007\/s11356-020-10113-7","article-title":"Synthesized chrysin-loaded nanoliposomes improves cadmium-induced toxicity in mice","volume":"27","author":"Beyrami","year":"2020","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.biopha.2023.115485_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.904973","article-title":"Satureja khuzistanica essential oil-loaded solid lipid nanoparticles modified with chitosan-folate: Evaluation of encapsulation efficiency, cytotoxic and pro-apoptotic properties","volume":"10","author":"Tabatabaeain","year":"2022","journal-title":"Front. Chem."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115485_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijpharm.2015.07.012","article-title":"Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine","volume":"492","author":"Dubey","year":"2015","journal-title":"Int J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115485_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2018.1526227","article-title":"Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice","volume":"25","author":"Chang","year":"2018","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2023.115485_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12645-022-00126-x","article-title":"Antiproliferation effects of nanophytosome-loaded phenolic compounds from fruit of Juniperus polycarpos against breast cancer in mice model: Synthesis, characterization and therapeutic effects","volume":"13","author":"Moeini","year":"2022","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.biopha.2023.115485_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijbiomac.2020.02.106","article-title":"Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles","volume":"152","author":"Akbarian","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2023.115485_bib37","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.2147\/IJN.S184379","article-title":"Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration","volume":"13","author":"Huang","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.biopha.2023.115485_bib38","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1208\/s12249-008-9146-5","article-title":"5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study","volume":"9","author":"Maghsoudi","year":"2008","journal-title":"Aaps Pharmscitech"},{"key":"10.1016\/j.biopha.2023.115485_bib39","first-page":"669","article-title":"Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles","volume":"5","author":"Zhao","year":"2010","journal-title":"Int. J. Nanomed."},{"issue":"12","key":"10.1016\/j.biopha.2023.115485_bib40","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1021\/acs.molpharmaceut.0c00963","article-title":"Chemical architecture of block copolymers differentially abrogate cardiotoxicity and maintain the anticancer efficacy of doxorubicin","volume":"17","author":"Abdullah","year":"2020","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2023.115485_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","article-title":"Albumin-based nanoparticles as potential controlled release drug delivery systems","volume":"157","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2023.115485_bib42","article-title":"Human serum albumin as multifunctional nanocarrier for cancer therapy","volume":"1","author":"Zeeshan","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2023.115485_bib43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2217\/nnm-2018-0046","article-title":"Sorafenib-loaded polymeric micelles as passive targeting therapeutic agents for hepatocellular carcinoma therapy","volume":"13","author":"Su","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2023.115485_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2021.109805","article-title":"Folic acid-functionalized tea polyphenol as a tumor-targeting nano-drug delivery system","volume":"206","author":"Chuan","year":"2021","journal-title":"Mater. Des."},{"issue":"5","key":"10.1016\/j.biopha.2023.115485_bib45","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1021\/acsami.7b18155","article-title":"Coordination-triggered hierarchical folate\/zinc supramolecular hydrogels leading to printable biomaterials","volume":"10","author":"Liu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2023.115485_bib46","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.msec.2017.02.118","article-title":"Fabrication of thermal sensitive folic acid based supramolecular hybrid gels for injectable drug release gels","volume":"75","author":"Song","year":"2017","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.biopha.2023.115485_bib47","doi-asserted-by":"crossref","DOI":"10.1039\/C7SC04004K","article-title":"Advances in targeting the folate receptor in the treatment\/imaging of cancers","volume":"9","author":"Fern\u00e1ndez","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2023.115485_bib48","article-title":"Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier","volume":"110","author":"Vinothini","year":"2019","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115485_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/nature12327","article-title":"Structural basis for molecular recognition of folic acid by folate receptors","volume":"500","author":"Chen","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2023.115485_bib50","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/bc400441s","article-title":"Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship","volume":"25","author":"Leamon","year":"2014","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biopha.2023.115485_bib51","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-018-1226-6","article-title":"Folic acid-functionalized gold nanorods for controlled paclitaxel delivery: in vitro evaluation and cell studies","author":"Papaioannou","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.biopha.2023.115485_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor \u03b1 in oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115485_bib53","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.addr.2004.01.002","article-title":"A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro","volume":"56","author":"Kamen","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115485_bib54","doi-asserted-by":"crossref","DOI":"10.2174\/1381612828666220506111918","article-title":"Functionalized PAMAM-based nanoformulation for targeted delivery of 5-fluorouracil in hepatocellular carcinoma","author":"Chen","year":"2022","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.biopha.2023.115485_bib55","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.biomaterials.2010.10.044","article-title":"Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery","volume":"32","author":"Jian","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2023.115485_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.598155","article-title":"Synthesis, characterization, cellular uptake, and in vitro anticancer activity of fullerenol-doxorubicin conjugates","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.biopha.2023.115485_bib57","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/smll.201300171","article-title":"Bright far\u2010red\/near\u2010infrared conjugated polymer nanoparticles for in vivo bioimaging","volume":"9","author":"Ding","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.biopha.2023.115485_bib58","first-page":"2019","article-title":"Folate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis models","volume":"9","author":"Zhang","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115485_bib59","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.2147\/IJN.S241448","article-title":"Lipoprotein-inspired nanocarrier composed of folic acid-modified protein and lipids: preparation and evaluation of tumor-targeting effect","volume":"15","author":"Han","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.biopha.2023.115485_bib60","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/acsomega.0c04350","article-title":"Self-assembled folic acid-targeted pectin-multi-arm polyethylene glycol nanoparticles for tumor intracellular chemotherapy","volume":"6","author":"Liu","year":"2021","journal-title":"ACS Omega"},{"issue":"18","key":"10.1016\/j.biopha.2023.115485_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700354","article-title":"Ultrasound\u2010triggered destruction of folate\u2010functionalized mesoporous silica nanoparticle\u2010loaded microbubble for targeted tumor therapy","volume":"6","author":"Lv","year":"2017","journal-title":"Adv. Healthc. Mater."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223012830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223012830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:36:05Z","timestamp":1776461765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223012830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":61,"alternative-id":["S0753332223012830"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115485","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Albumin nanoparticles and their folate modified counterparts for delivery of a lupine derivative to hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115485"}}